These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 12591732

  • 1. Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significance.
    Chen YJ, Vortmeyer A, Zhuang Z, Huang S, Jensen RT.
    Cancer Res; 2003 Feb 15; 63(4):817-23. PubMed ID: 12591732
    [Abstract] [Full Text] [Related]

  • 2. X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growth.
    Chen YJ, Vortmeyer A, Zhuang Z, Gibril F, Jensen RT.
    Cancer; 2004 Apr 01; 100(7):1379-87. PubMed ID: 15042671
    [Abstract] [Full Text] [Related]

  • 3. Her-2/neu expression and gene amplification in gastrinomas: correlations with tumor biology, growth, and aggressiveness.
    Goebel SU, Iwamoto M, Raffeld M, Gibril F, Hou W, Serrano J, Jensen RT.
    Cancer Res; 2002 Jul 01; 62(13):3702-10. PubMed ID: 12097278
    [Abstract] [Full Text] [Related]

  • 4. Chromosome 1q loss of heterozygosity frequently occurs in sporadic insulinomas and is associated with tumor malignancy.
    Yang YM, Liu TH, Chen YJ, Jiang WJ, Qian JM, Lu X, Gao J, Wu SF, Sang XT, Chen J.
    Int J Cancer; 2005 Nov 01; 117(2):234-40. PubMed ID: 15900598
    [Abstract] [Full Text] [Related]

  • 5. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors.
    Debelenko LV, Zhuang Z, Emmert-Buck MR, Chandrasekharappa SC, Manickam P, Guru SC, Marx SJ, Skarulis MC, Spiegel AM, Collins FS, Jensen RT, Liotta LA, Lubensky IA.
    Cancer Res; 1997 Jun 01; 57(11):2238-43. PubMed ID: 9187127
    [Abstract] [Full Text] [Related]

  • 6. Increased expression of insulin-like growth factor I and/or its receptor in gastrinomas is associated with low curability, increased growth, and development of metastases.
    Furukawa M, Raffeld M, Mateo C, Sakamoto A, Moody TW, Ito T, Venzon DJ, Serrano J, Jensen RT.
    Clin Cancer Res; 2005 May 01; 11(9):3233-42. PubMed ID: 15867218
    [Abstract] [Full Text] [Related]

  • 7. Deletion of chromosome 1 predicts prognosis in pancreatic endocrine tumors.
    Ebrahimi SA, Wang EH, Wu A, Schreck RR, Passaro E, Sawicki MP.
    Cancer Res; 1999 Jan 15; 59(2):311-5. PubMed ID: 9927038
    [Abstract] [Full Text] [Related]

  • 8. Deletion of chromosome 1, but not mutation of MEN-1, predicts prognosis in sporadic pancreatic endocrine tumors.
    Guo SS, Wu AY, Sawicki MP.
    World J Surg; 2002 Jul 15; 26(7):843-7. PubMed ID: 11960210
    [Abstract] [Full Text] [Related]

  • 9. Allelic imbalance of chromosome 1q in esophageal squamous cell carcinomas from China: a novel region of allelic loss and significant association with differentiation.
    Li J, Liu Z, Wang Y, Yu Z, Wang M, Zhan Q, Liu Z.
    Cancer Lett; 2005 Apr 08; 220(2):221-30. PubMed ID: 15766597
    [Abstract] [Full Text] [Related]

  • 10. Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.
    Mihaila D, Jankowski M, Gutiérrez JA, Rosenblum ML, Newsham IF, Bögler O, Rempel SA, NABTT CNS Consortium.
    Clin Cancer Res; 2003 Oct 01; 9(12):4443-51. PubMed ID: 14555517
    [Abstract] [Full Text] [Related]

  • 11. Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival.
    Maru DM, Luthra R, Correa AM, White-Cross J, Anandasabapathy S, Krishnan S, Guha S, Komaki R, Swisher SG, Ajani JA, Hofstetter WL, Rashid A.
    Cancer; 2009 Apr 01; 115(7):1576-85. PubMed ID: 19156915
    [Abstract] [Full Text] [Related]

  • 12. [Refined mapping of the loss of heterozygosity on chromosome 1q21 in gastric carcinoma].
    Liu TF, Yin ZH, Gan RL, Zhao Q, Dong L, Zhou JG, Dong BH.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul 01; 28(7):1229-32. PubMed ID: 18676271
    [Abstract] [Full Text] [Related]

  • 13. [Frequent loss of heterozygosity at MEN-1 gene and chromosome 22q in insulinomas and its significance].
    Jiang WJ, Liu TH, Chen J, Gao J, Wu SF, Chen YJ.
    Zhonghua Yi Xue Za Zhi; 2004 Oct 17; 84(20):1705-9. PubMed ID: 15569430
    [Abstract] [Full Text] [Related]

  • 14. Survey of genetic alterations in gastrinomas.
    Yu F, Jensen RT, Lubensky IA, Mahlamaki EH, Zheng YL, Herr AM, Ferrin LJ.
    Cancer Res; 2000 Oct 01; 60(19):5536-42. PubMed ID: 11034099
    [Abstract] [Full Text] [Related]

  • 15. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 16. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF, Tang PZ, Cheng SJ.
    Ai Zheng; 2003 May 01; 22(5):452-7. PubMed ID: 12753701
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of epidermal growth factor and hepatocyte growth factor receptors in a proportion of gastrinomas correlates with aggressive growth and lower curability.
    Peghini PL, Iwamoto M, Raffeld M, Chen YJ, Goebel SU, Serrano J, Jensen RT.
    Clin Cancer Res; 2002 Jul 01; 8(7):2273-85. PubMed ID: 12114431
    [Abstract] [Full Text] [Related]

  • 18. Loss of heterozygosity at 1p36 predicts poor prognosis in gastrointestinal stromal/smooth muscle tumors.
    O'Leary T, Ernst S, Przygodzki R, Emory T, Sobin L.
    Lab Invest; 1999 Dec 01; 79(12):1461-7. PubMed ID: 10616197
    [Abstract] [Full Text] [Related]

  • 19. Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas.
    Goebel SU, Heppner C, Burns AL, Marx SJ, Spiegel AM, Zhuang Z, Lubensky IA, Gibril F, Jensen RT, Serrano J.
    J Clin Endocrinol Metab; 2000 Jan 01; 85(1):116-23. PubMed ID: 10634374
    [Abstract] [Full Text] [Related]

  • 20. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.
    Gicquel C, Bertagna X, Gaston V, Coste J, Louvel A, Baudin E, Bertherat J, Chapuis Y, Duclos JM, Schlumberger M, Plouin PF, Luton JP, Le Bouc Y.
    Cancer Res; 2001 Sep 15; 61(18):6762-7. PubMed ID: 11559548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.